Abstract
Objective:
To review the clinical management of Tourette's syndrome (TS) and the associated disorders, namely obsessive-compulsive disorder (OCD) and attention deficit hyperactivity disorder (ADHD) with an emphasis on the pharmacologic intervention strategies.
Method:
English language literature on the pharmacologic management of TS and the associated disorders published between 1985 and 1994 was critically reviewed.
Results:
Pharmacologic management was placed in the context of the overall clinical management. Pharmacologic strategies for treatment of TS, OCD and ADHD were organized according to the therapeutic agent class.
Conclusions:
The treatment of TS and its associated disorders requires the application of the full range of psychiatric skills to achieve a favourable outcome.
MeSH terms
-
Adolescent
-
Antipsychotic Agents / adverse effects
-
Antipsychotic Agents / therapeutic use
-
Attention Deficit Disorder with Hyperactivity / diagnosis
-
Attention Deficit Disorder with Hyperactivity / drug therapy
-
Attention Deficit Disorder with Hyperactivity / psychology
-
Central Nervous System Stimulants / adverse effects
-
Central Nervous System Stimulants / therapeutic use
-
Child
-
Combined Modality Therapy
-
Humans
-
Obsessive-Compulsive Disorder / diagnosis
-
Obsessive-Compulsive Disorder / drug therapy
-
Obsessive-Compulsive Disorder / psychology
-
Psychotherapy
-
Psychotropic Drugs / adverse effects
-
Psychotropic Drugs / therapeutic use
-
Tourette Syndrome / diagnosis
-
Tourette Syndrome / drug therapy*
-
Tourette Syndrome / psychology
-
Treatment Outcome
Substances
-
Antipsychotic Agents
-
Central Nervous System Stimulants
-
Psychotropic Drugs